Results 221 to 230 of about 2,747,170 (398)
Predicting immune responses to treatments, including nanomedicines, with high throughput test is challenging due to the immunoreactome's complexity and plasticity. A predictive screening platform integrating pathway activation and gene profiling in macrophages has been developed as a versatile tool for designing effective immunotherapies.
Sonia Becharef+12 more
wiley +1 more source
Gene therapy and viral vectors. Herpes Simplex Virus as a Vector for Gene Therapy.
Shin‐Ichi Miyatake
openalex +2 more sources
AAV2.7m8 serotype combined with the gfaABC1D promoter targets infection of supporting cells (SCs). AAV2.7m8‐gfaABC1D‐Gjb2 administration to mice results in excessive immune responses. The combination of AAV2.7m8‐gfaABC1D‐Gjb2 with dexamethasone (DEX) shows a synergistic effect and enhances the gene therapy effect in a conditional Cx26 null mice model ...
Xiaohui Wang+8 more
wiley +1 more source
Background & aim: Crimean–Congo hemorrhagic fever (CCHF) is a potentially lethal systemic viral disease in human beings, which is transmitted by tick bites.
F Farhadpour+5 more
doaj
Bilirubin Targeting WNK1 to Alleviate NLRP3‐Mediated Neuroinflammation
At physiological concentrations, bilirubin binds to the kinase domain of WNK1, thereby augmenting its activity and facilitating the phosphorylation of downstream SPAK/OSR1. This phosphorylation inhibits KCC2 activity, leading to elevate intracellular chloride levels in neurons.
Linfei Mao+14 more
wiley +1 more source
Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model [PDF]
Alberto Auricchio
openalex +1 more source
Current preclinical studies of AAV‐mediated gene therapy explore different strategies based on the characteristics of inner ear diseases. For genetic hearing loss, approaches include the replacement of a “good gene,” removal of a “bad gene,” or direct correction of mutations through base editing.
Fan Wu+7 more
wiley +1 more source
Past, Present, and Future of Viral Vector Vaccine Platforms: A Comprehensive Review. [PDF]
Tang J, Amin MA, Campian JL.
europepmc +1 more source
An investigation of excipients for a stable Orf viral vector formulation. [PDF]
Eilts F+5 more
europepmc +1 more source